[Suppressive mechanism of clarithromycin on lipopolysaccharide-induced IL-8 production in human monocytes by mediating AP-1 and NF-kappaB].
Kikuchi
Toru
T
Hagiwara
Koichi
K
Honda
Yoshihiro
Y
Watanabe
Akira
A
Nukiwa
Toshihiro
T
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002478:Cells, Cultured; D017291:Clarithromycin / Q000494:pharmacology*; D003864:Depression, Chemical; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D016209:Interleukin-8 / Q000096:biosynthesis* / Q000235:genetics; D008070:Lipopolysaccharides / Q000494:pharmacology*; D009000:Monocytes / Q000378:metabolism*; D016328:NF-kappa B / Q000502:physiology*; D011401:Promoter Regions, Genetic / Q000235:genetics; D018808:Transcription Factor AP-1 / Q000502:physiology*
D000900:Anti-Bacterial Agents; D016209:Interleukin-8; D008070:Lipopolysaccharides; D016328:NF-kappa B; D018808:Transcription Factor AP-1; D017291:Clarithromycin